Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients

NCT02622581 is registered in ClinicalTrials.gov with AIO-Studien-gGmbH as lead sponsor.

NCT NCT02622581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02622581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
Lead sponsor
AIO-Studien-gGmbH
Phase
Observational
Overall status
Recruiting
Start date
December 31, 2015
Completion date
September 30, 2031
Enrollment
14,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic non-small cell lung cancer (nsclc), non small cell lung cancer stage iii, non-small cell lung cancer metastatic, non-small cell lung cancer stage i, non-small cell lung cancer stage ii, small-cell lung cancer